Kinfo
AzurRx BioPharma Inc logo

AzurRx BioPharma Inc

AZRXNASDAQ·US · USD
$4.50
+0.34 (+8.17%)
Prices as of July 10, 2026 · market closed

Price

Key statistics

Valuation
Market cap341.80M USD
Enterprise value336.37M USD
Trailing P/E-0.39
Forward P/E-12.32
PEG ratio0.01
Price / sales0.00
Price / book-3.62
Profitability
Gross margin0.00%
Operating margin0.00%
Profit margin0.00%
Return on assets-680.16%
Return on equity43.26%
Income (TTM)
Revenue0.00 USD
Gross profit0.00 USD
EBITDA0.00 USD
Net income-41.73M USD
Diluted EPS-$11.50
Rev. growth (YoY)0.00%
Balance sheet
Total cash0.00 USD
Total debt390.48K USD
Debt / equity-0.00
Current ratio0.39
Book value / share-$15.41
Cash flow (TTM)
Operating cash flow-24.42M USD
Levered free cash flow-41.73M USD
Shares & price
Shares outstanding78.58M
Float0.00
Held by institutions0.00%
Beta0.00
50-day MA$0.00
200-day MA$0.00
52-week high$6.93
52-week low$0.40
Earnings (EPS)
DateEst.ActualSurprise2021-08-16-0.72-1.60−122.22%2021-05-24-0.72-1.40−94.44%2021-03-31-1.36-3.10−127.94%2020-11-16-1.36-4.70−245.59%2020-08-14-1.06-1.70−60.38%

Frequently asked questions about AzurRx BioPharma Inc